Novavax

NVAX

NVAX
Novavax Stock Quote
$3.75 -$0.08 -2.1%
BATS BZX Real Time Price as of November 19, 2019, 4:00 p.m. EST View Interactive NVAX Charts

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.

News & Analysis: Novavax

The Fool has written over 200 articles on Novavax.

All

Market Moves

Podcasts

Earnings

One Biotech Crashes, the Other Skyrockets -- Here's Why

Hit-or-miss data, delays, and contentious debate preceded the FDA's green-lighting of the first drug to target the cause of Duchenne muscular dystrophy. Meanwhile, a disappointing data readout stops one vaccine maker in its tracks.


Interactive Chart